Get the Stockscreener App
0.46
0.00%
0.00
Citius Pharmaceuticals Inc Stock (CTXR) Forecast
The Citius Pharmaceuticals Inc (CTXR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.8931, representing a +528.93% increase from the current price of $0.46. The highest analyst price target is $3.9446, and the lowest is $1.8415.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CTXR Price Target
Average 9.4802
(+1,961% Upside)
Is Citius Pharmaceuticals Inc (CTXR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 33.53 | Neutral |
| STOCH(9,6) | 14.99 | Buy |
| STOCHRSI(14) | 2.6038 | Buy |
| MACD(12,26) | -0.0315 | Sell |
| ADX(14) | 22.87 | Neutral |
| William %R | -91.71 | Buy |
| CCI(14) | -62.09 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4844
Sell
|
0.4861
Sell
|
| MA20 |
0.5221
Sell
|
0.5121
Sell
|
| MA50 |
0.5777
Sell
|
0.5521
Sell
|
| MA100 |
0.5755
Sell
|
0.598
Sell
|
| MA200 |
0.6783
Sell
|
0.7327
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CTXR could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on CTXR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.53 indicates that CTXR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 14.99 indicates that CTXR is oversold. This indicates that CTXR price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.6038 indicates that CTXR is oversold. This suggests that CTXR price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.87 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -62.09 indicates that CTXR is still oversold but not to an extreme extent.
Long-term CTXR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Citius Pharmaceuticals Inc financial reports and earnings history, Citius Pharmaceuticals Inc (CTXR) stock could reach $6.6097 by 2030, $63.76 by 2040 and $189.33 by 2050. See the projected annual prices until 2050 of the Citius Pharmaceuticals Inc stock below:
- Citius Pharmaceuticals Inc (CTXR) is expected to reach an average price of $35.57 in 2035, with a high prediction of $36.09 and a low estimate of $35.31. This indicates an $7,632% rise from the last recorded price of $0.46.
- Citius Pharmaceuticals Inc (CTXR) stock is projected to chart a bullish course in 2040, with an average price target of $65.27, representing an $14,089% surge from its current level. The forecast ranges from a conservative $65.46 to a sky-high $63.76.
- Our analysts predict Citius Pharmaceuticals Inc (CTXR) to jump 25,992% by 2045, soaring from $120.07 to an average price of $120.02, potentially reaching $120.11. While $120.07 is the low estimate, the potential upside is significant.
- Citius Pharmaceuticals Inc (CTXR) stock is expected to climb by 2050, reaching an average of $189.40, a $41,073% jump from its current level. However, a wide range of estimates exists, with high and low targets of $189.33 and $190.77, respectively, highlighting the market's uncertainty.
Citius Pharmaceuticals Inc Stock (CTXR) Year by Year Forecast
Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2026
The predicted value for Citius Pharmaceuticals Inc (CTXR) in 2026 is set at an average of $3.1426. Estimates vary from a peak of $5.835 to a trough of $0.4501, indicating an +583.16% surge from the present price of $0.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $4.9446 | $1.8415 | $3.9446 | +974.92% |
| December, 2026 | $4.5477 | $8.4595 | $4.2977 | +888.64% |
Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Citius Pharmaceuticals Inc (CTXR) is $9.4802, with a high forecast of $18.67 and a low forecast of $0.2941. This indicates an +1,961% increase from the last price of $0.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.1508 | $7.9743 | $5.6876 | +1,889% |
| February, 2027 | $7.5039 | $9.0039 | $7.8274 | +1,531% |
| March, 2027 | $5.9453 | $6.8937 | $5.607 | +1,192% |
| April, 2027 | $1.4516 | $0.2941 | $4.1257 | +215.57% |
| May, 2027 | $16.99 | $5.8867 | $14.36 | +3,593% |
| June, 2027 | $18.85 | $19.84 | $18.67 | +3,998% |
| July, 2027 | $17.28 | $19.34 | $17.43 | +3,656% |
| August, 2027 | $16.31 | $18.76 | $17.90 | +3,446% |
| September, 2027 | $10.74 | $11.98 | $16.88 | +2,235% |
| October, 2027 | $6.5935 | $9.0935 | $7.9169 | +1,333% |
| November, 2027 | $11.78 | $10.18 | $9.5349 | +2,462% |
| December, 2027 | $12.64 | $11.55 | $10.89 | +2,647% |
Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2028
In 2028, Citius Pharmaceuticals Inc (CTXR) is projected to reach an average price of $7.4585, with a high projection of $14.81 and a low estimate of $0.1096. This indicates an +1,521% rise from the last price of $0.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.5793 | $8.0793 | $10.73 | +1,330% |
| February, 2028 | $16.93 | $9.6151 | $14.81 | +3,581% |
| March, 2028 | $3.0355 | $7.5355 | $13.78 | +559.89% |
| April, 2028 | $4.8886 | $2.2121 | $3.3886 | +962.74% |
| May, 2028 | $9.08 | $7.0651 | $7.33 | +1,874% |
| June, 2028 | $7.0669 | $0.1831 | $8.1682 | +1,436% |
| July, 2028 | $3.6244 | $0.1096 | $8.9787 | +687.92% |
| August, 2028 | $2.1025 | $2.7275 | $3.801 | +357.07% |
| September, 2028 | $1.8306 | $1.1541 | $3.0077 | +297.96% |
| October, 2028 | $7.997 | $2.4189 | $6.092 | +1,638% |
| November, 2028 | $7.5701 | $7.6251 | $6.451 | +1,546% |
| December, 2028 | $12.28 | $7.7133 | $10.20 | +2,570% |
Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2029
The 2029 price forecast for Citius Pharmaceuticals Inc Stock (CTXR) is $5.8707 on average, with a high prediction of $11.72 and a low estimate of $0.0199. This represents an +1,176% increase from the previous price of $0.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $10.47 | $12.33 | $11.72 | +2,175% |
| February, 2029 | $8.9501 | $9.5176 | $9.4003 | +1,846% |
| March, 2029 | $6.2632 | $8.6057 | $8.4124 | +1,262% |
| April, 2029 | $8.0671 | $7.9788 | $7.3421 | +1,654% |
| May, 2029 | $10.53 | $8.6554 | $9.9227 | +2,189% |
| June, 2029 | $6.3158 | $7.0233 | $9.2585 | +1,273% |
| July, 2029 | $2.2821 | $5.3396 | $6.3281 | +396.12% |
| August, 2029 | $7.4477 | $2.0529 | $4.0777 | +1,519% |
| September, 2029 | $7.2108 | $6.7443 | $5.9233 | +1,468% |
| October, 2029 | $7.3872 | $7.5016 | $6.2764 | +1,506% |
| November, 2029 | $2.1703 | $3.8028 | $7.0222 | +371.80% |
| December, 2029 | $6.0792 | $0.0199 | $4.9316 | +1,222% |
Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2030
Citius Pharmaceuticals Inc Stock (CTXR) is expected to reach an average price of $10.95 in 2030, with a high forecast of $15.07 and a low forecast of $6.8207. This signifies an +2,280% surge from the last price of $0.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.5122 | $6.8207 | $6.6097 | +1,533% |
| February, 2030 | $9.0128 | $7.6863 | $7.1128 | +1,859% |
| March, 2030 | $9.8984 | $10.33 | $9.3777 | +2,052% |
| April, 2030 | $15.09 | $10.22 | $13.80 | +3,180% |
| May, 2030 | $14.08 | $15.17 | $15.07 | +2,961% |
| June, 2030 | $13.81 | $13.73 | $13.36 | +2,903% |
| July, 2030 | $14.50 | $13.92 | $13.88 | +3,053% |
| August, 2030 | $14.14 | $14.18 | $14.32 | +2,973% |
| September, 2030 | $13.88 | $13.91 | $13.91 | +2,918% |
| October, 2030 | $13.45 | $13.55 | $13.73 | +2,824% |
| November, 2030 | $12.70 | $12.88 | $13.05 | +2,662% |
| December, 2030 | $10.54 | $11.15 | $11.99 | +2,191% |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):